Steripath Micro available for use in children’s hospitals

Create PDF

October 2021—Magnolia Medical Technologies announced the commercial availability of its Steripath Micro Initial Specimen Diversion Device designed for use in children’s hospitals. Steripath Micro is an FDA 510(k)-cleared device with the specific indication to reduce blood culture contamination. The small, lightweight device requires less than 1 mL of blood for patients with limited volumes or difficult intravenous access. The company says Steripath Micro has shown a zero percent contamination rate in two leading children’s hospitals during a three- month period.